Avid Bioservices Inc (CDMO)

[pphmtoolong]

Come on guys. Sometimes a cigar is just a cigar. The rapid growth of the Sunrise trial site count is most likely due three factors. One, a very determined Peregrine management. Two, the crying need for new treatments. And three, the very promising results of the Phase II trial. We don't have any solid reason to believe Peregrine has some kind of understanding with a BP that is accelerating the trial.

If Peregrine did have any kind of deal with a BP, wouldn't they be required to disclose it? Even if the BP wanted it kept quiet for some reason?

It can't be long now before Bavi is treating more patients in this trial than all previous trials combined. Very exciting. Even more exciting than discussions about employee stock ownership.

GLTA, Paul